BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6100268)

  • 1. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology of hepatocellular carcinoma in Africa.
    Olweny CL
    IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does hepatitis B virus cause hepatocellular carcinoma?
    Trichopoulos D; Kremastinou J; Tzonou A
    IARC Sci Publ; 1982; (39):317-32. PubMed ID: 6295934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
    Harris CC; Sun TT
    Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: risk factors other than HBV.
    Villa E; Melegari M; Scaglioni PP; Trande P; Cesaro P; Manenti F
    Ital J Gastroenterol; 1991; 23(7):457-60. PubMed ID: 1660333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between hepatocellular carcinoma and cirrhosis.
    Kew MC; Popper H
    Semin Liver Dis; 1984 May; 4(2):136-46. PubMed ID: 6087459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions.
    Bosch FX; Muñoz N
    IARC Sci Publ; 1988; (89):427-38. PubMed ID: 2848766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
    Yeh FS; Mo CC; Yen RC
    Natl Cancer Inst Monogr; 1985 Dec; 69():47-8. PubMed ID: 3010122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical carcinogenesis: mycotoxins and other chemicals to which humans are exposed.
    Newberne PM
    Semin Liver Dis; 1984 May; 4(2):122-35. PubMed ID: 6087458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.
    Omer RE; Kuijsten A; Kadaru AM; Kok FJ; Idris MO; El Khidir IM; van 't Veer P
    Nutr Cancer; 2004; 48(1):15-21. PubMed ID: 15203373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respective roles of aflatoxin and hepatitis B in the etiology of primary cancer of the liver in man].
    Stora C; Dvorackova I
    Bull Acad Natl Med; 1986 Jun; 170(6):763-75. PubMed ID: 3026585
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
    Bréchot C; Minami M; De Mitri S; Paterlini P
    Princess Takamatsu Symp; 1995; 25():199-209. PubMed ID: 8875625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.